Diane Gesty-Palmer, MD, PhD

Diane is a Board-Certified endocrinologist and Senior Medical Director supporting the Cardiovascular, Metabolic, Endocrine and Renal therapeutic areas at Fortrea. Dr.

Friedrich Mittermayer, MD, MSc

Friedrich is a board-certified Endocrinologist and Internal Medicine specialist who has >25 years experience in clinical trials and medical practice.

James Joyce, MPH

James Joyce is a Delivery Director within the Biopharma group of Global Project Delivery, specializing in Phase Ib through Phase III studies in Obesity as well as Liver Disease including MASH/MASLD (metabolic dysfunction-associated steatohepatitis

Clinical trials: Using AI to drive productivity in clinical development

Modern clinical trials: Apply a mix of co-innovation and best practices to improve productivity and drive ROI

Practical considerations for cell and gene therapy trials in neonates and young children living with rare diseases

Breaking the stigma: Understanding obesity as a chronic disease

To shine the spotlight on World Obesity Day, our team at Fortrea recently interviewed Sarah Le Brocq, an obesity advocate, public speaker and patient leader, Sarah shared her insights on living with obesity.

Rare Disease Day: Celebrating progress and hope for the future

Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.